We recently reported claims that the DEA has granted unnamed private pharmaceutical companies license to grow cannabis for experimental purposes. Now, the Sacramento News & Review on Dec. 19 cites a report from the Union of Medical Marijuana Patients to the effect that the United States government holds a patent on the use of cannabinoids as "antioxidants and neuroprotectants"—specifically, the Department of Health & Human Services holds Patent #6630507, as documented at the US Patent & Trademark Office.
Recent comments
12 weeks 2 days ago
16 weeks 3 days ago
18 weeks 14 hours ago
18 weeks 1 day ago
30 weeks 3 days ago
36 weeks 1 day ago
47 weeks 1 day ago
48 weeks 23 hours ago
49 weeks 4 days ago
50 weeks 1 day ago